Skip to Content

Kaken Pharmaceutical Co Ltd KKPCF

Morningstar Rating
$22.30 −1.66 (6.91%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

KKPCF is trading at a 14% discount.
Price
$22.18
Fair Value
$46.45
Uncertainty
High
1-Star Price
$44.31
5-Star Price
$76.20
Economic Moat
Bmsjy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if KKPCF is a good fit for your portfolio.

Trading Information

Previous Close Price
$23.96
Day Range
$22.3022.30
52-Week Range
$22.3029.27
Bid/Ask
$20.31 / $23.86
Market Cap
$844.50 Mil
Volume/Avg
200 / 497

Key Statistics

Price/Earnings (Normalized)
28.68
Price/Sales
1.64
Dividend Yield (Trailing)
4.51%
Dividend Yield (Forward)
0.03%
Total Yield
4.51%

Company Profile

Kaken Pharmaceutical Co is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
1,324

Comparables

Valuation

Metric
KKPCF
4554
9273
Price/Earnings (Normalized)
28.687.537.52
Price/Book Value
0.850.901.49
Price/Sales
1.640.911.47
Price/Cash Flow
18.183.899.09
Price/Earnings
KKPCF
4554
9273

Financial Strength

Metric
KKPCF
4554
9273
Quick Ratio
4.640.682.76
Current Ratio
5.641.464.14
Interest Coverage
189.2255.27634.44
Quick Ratio
KKPCF
4554
9273

Profitability

Metric
KKPCF
4554
9273
Return on Assets (Normalized)
3.00%3.39%15.34%
Return on Equity (Normalized)
3.64%7.02%20.94%
Return on Invested Capital (Normalized)
3.25%4.22%18.19%
Return on Assets
KKPCF
4554
9273
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRKtzhmdysgqRgvkq$70.5 Bil
ZTS
Zoetis Inc Class ALzqwxffzDwwtb$69.4 Bil
HLN
Haleon PLC ADRRmknxgqhJdkq$36.6 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRQsxzccvXrrb$14.9 Bil
VTRS
Viatris IncXcwxkjjtYmhv$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRWpnhcbncJjdh$12.0 Bil
CTLT
Catalent IncYmybqdfvXqvhj$10.1 Bil
PRGO
Perrigo Co PLCXmfqskcvWzhd$4.1 Bil
CURLF
Curaleaf Holdings IncNdctkqckZyj$3.7 Bil
PBH
Prestige Consumer Healthcare IncWlhhbkhdLzhfdhb$3.4 Bil

Sponsor Center